Durham's SCYNEXIS, Inc. Files For $55 Million IPO

Published: Mar 03, 2014

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Durham pharmaceutical company Scynexis filed to go public with the intent to raise $55 million through an initial public offering. The company spun out from Aventis S.A, in 2000 as a chemistry and animal health services company, providing contract research services to third parties. Since then, it has generated revenue from providing these services to human and animal health companies to assist them in developing their own drug candidates.

Help employers find you! Check out all the jobs and post your resume.

Back to news